Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension

NCT06153693 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1083

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Placebo
DRUG: lorundrostat Dose 1
DRUG: lorundrostat Dose 2

Sponsor

Mineralys Therapeutics Inc.